Characterization of the Enhancing Effect of Protamine on the Proliferative Activity of Hepatocyte Growth Factor in Rat Hepatocytes
- 118 Downloads
The aim of the present study was to characterize the mechanism of the stimulatory effect of protamine on HGF activity.
The enhancing effects of protamine on the proliferative activity of HGF were investigated in vivo, in primary cultured rat hepatocytes, and in perfused rat liver.
In α-naphthylisothiocyanate-intoxicated rats, pretreatment with protamine increased HGF-induced autophosphorylation of the HGF receptor in liver. The maximum enhancing effect of protamine on HGF-induced DNA synthesis of hepatocytes required a 10 min-pretreatment period both in vivo and in vitro, and the stimulatory effect of protamine was not observed when it was administered simultaneously with HGF. Preperfusion of the liver with protamine for 10 min decreased the non-saturable portion of hepatic clearance for 125I-HGF, which is mainly mediated by cell-surface heparan-sulfate proteoglycan (HSPG). Inhibition of HGF binding to heparin by protamine was confirmed using heparin-coated sepharose. This inhibition also required 10 min of pretreatment, for protamine to bind heparin.
The enhancing effect of protamine on the mitogenic activity of HGF on hepatocytes requires pretreatment with protamine for a short period presumably required for its binding to cell-surface heparin, implying possible regulation of c-met autophosphorylation by HSPG.
KEY WORDSclearance heparan-sulfate proteoglycan (HSPG) heparin hepatocyte growth factor (HGF) protamine
- 13.Y. H. Lee, Y. J. Suzuki, A. J. Griffin, and R. M. Day. Hepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells. Am. J. Physiol. 294:L778–L786 (2008).Google Scholar
- 15.C. C. Lee, and K. M. Yamada. Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte growth factor receptor. J. Biol. Chem. 270:507–510 (1995). doi: 10.1074/jbc.270.2.507.PubMedCrossRefGoogle Scholar
- 18.K. X. Liu, Y. Kato, T. Terasaki, S. Aoki, K. Okumura, T. Nakamura, and Y. Sugiyama. Contribution of parenchymal and non-parenchymal liver cell to the clearance of hepatocyte growth factor from the circulation in rats. Pharm. Res. 12:737–1740 (1995).Google Scholar
- 26.S. Miyauchi, Y. Sawada, T. Iga, M. Hanano, and Y. Sugiyama. Comparison of the hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers. Pharm. Res. 10:434–440 (1993). doi: 10.1023/A:1018952709120.PubMedCrossRefGoogle Scholar
- 31.E. Moreno, J. C. Meneu, J. Calvo, B. Perez, A. G. Sesma, A. Manrique, I. Vegh, A. M. Aragon, M. Grau, A. Gimeno, C. Jimenez, R. Gomez, A. Moreno, M. Abradelo, I. Garcia, and A. de la Calle. Modulation of hepatocyte growth factor plasma levels in relation to the dose of exogenous heparin administered: an experimental study in rats. Transplant. Proc. 37:3943–3947 (2005). doi: 10.1016/j.transproceed.2005.10.089.PubMedCrossRefGoogle Scholar
- 32.D. C. West, C. G. Rees, L. Duchesne, S. J. Patey, C. J. Terry, J. E. Turnbull, M. Delehedde, C. W. Heegaard, F. Allain, C. Vanpouille, D. Ron, and D. G. Fernig. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J. Biol. Chem. 280:13457–13464 (2005). doi: 10.1074/jbc.M410924200.PubMedCrossRefGoogle Scholar
- 34.R. H. Schwall, L. Y. Chang, P. J. Godowski, D. W. Kahn, K. J. Hillan, K. D. Bauer, and T. F. Zioncheck. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J .Cell Biol. 133:709–718 (1996). doi: 10.1083/jcb.133.3.709.PubMedCrossRefGoogle Scholar
- 35.M. Machide, K. Kamitori, and S. Kohsaka. Hepatocyte growth factor-induced differential activation of phospholipase Cgamma1 and phosphatidylinositol 3-kinase is regulated by tyrosine phosphatase, SHP-1 in astrocytes. J. Biol. Chem. 275:31392–31398 (2000). doi: 10.1074/jbc.M002817200.PubMedCrossRefGoogle Scholar
- 38.Y. Okano, K. Mizuno, S. Osada, T. Nakamura, and Y. Nozawa. Tyrosine phosphorylation of phospholipase C gamma in c-met/HGF receptor-stimulated hepatocytes: comparison with HepG2 hepatocarcinoma cells. Biochem. Biophys. Res. Commun. 190:842–842 (1993). doi: 10.1006/bbrc.1993.1125.PubMedCrossRefGoogle Scholar